St James’s Place PLC (LON:STJ) Rating Reaffirmed
Goldman Sachs now has a GBX 1050.00 TP on shares of St James’s Place PLC (LON:STJ). The TP may imply a potential upside of 4.56% from the close price of St James’s Place PLC (LON:STJ). This rating was revealed to investors in a note on 27 November.
From a total of 18 analysts covering St James’s Place PLC (LON:STJ) stock, 11 rate it a ”Buy”, 2 a “Sell”, and 5 a ”Hold”. This means that 61% of the ratings are positive. The highest target price is GBX 1141 while the lowest target price is GBX 1. The mean of all analyst targets is GBX 1029.71 with a 2.54% above today’s (GBX 1004.24) stock price. St James’s Place PLC was the topic of 45 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Goldman Sachs maintained shares on November 27 with “Buy” rating. Deutsche Bank maintained shares with “Buy” rating and GBX 980 target share price in a report from an October 28. Credit Suisse maintained STJ stock in a recent report from November 5 with “Neutral” rating. Numis Securities maintained the rating on October 27. Numis Securities has a “Hold” rating and a GBX 925 price target on shares. Finally, Barclays Capital maintained the stock with “Overweight” rating in a report issued on an October 28.
The stock increased 0.02% or GBX 0.24 on November 26, striking GBX 1004.24. Approximately shares of stock traded hands. St. James’s Place plc (LON:STJ) has risen 12.49% since April 30, 2015 and is uptrending. It has outperformed by 13.85% the S&P500.
St. James’s Place plc is a United Kingdom parent firm of the St. The company has a market cap of 5.26 billion GBP. James’s Place Wealth Management Group, which provides wealth management advice, investment management and related services to businesses and individuals across the United Kingdom. It has 29.89 P/E ratio. The Firm operates in four divisions: Life, Unit Trust, Distribution and Other.
According to Zacks Investment Research, “St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation.” Get a free copy of the Zacks research report on St. James’s Place plc (STJ)